For: | Eltobgy MM, Zani A, Kenney AD, Estfanous S, Kim E, Badr A, Carafice C, Daily K, Whitham O, Pietrzak M, Webb A, Kawahara J, Eddy AC, Denz P, Lu M, Kc M, Peeples ME, Li J, Zhu J, Que J, Robinson R, Rosas Mejia O, Rayner RE, Hall-Stoodley L, Seveau S, Gavrilin MA, Zhang X, Thomas J, Kohlmeier JE, Suthar MS, Oltz E, Tedeschi A, Robledo-Avila FH, Partida-Sanchez S, Hemann EA, Abdelrazik E, Forero A, Nimjee SM, Boyaka PN, Cormet-Boyaka E, Yount JS, Amer AO. Caspase-4/11 exacerbates disease severity in SARS-CoV-2 infection by promoting inflammation and immunothrombosis. Proc Natl Acad Sci U S A 2022;119:e2202012119. [PMID: 35588457 DOI: 10.1073/pnas.2202012119] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis] |
---|
Number | Citing Articles |
1 | Speaks S, Zani A, Solstad A, Kenney A, Zhang L, Eddy AC, Amer AO, Robinson R, Cai C, Ma J, Hemann EA, Forero A, Yount JS. Loss of Gasdermin D is protective against influenza virus-induced inflammation and mortality. bioRxiv 2023:2023. [PMID: 36945485 DOI: 10.1101/2023.03.08.531787] [Reference Citation Analysis] |
2 | Ryan TAJ, O'Neill LAJ. An Emerging Role for Type I Interferons as Critical Regulators of Blood Coagulation. Cells 2023;12. [PMID: 36899914 DOI: 10.3390/cells12050778] [Reference Citation Analysis] |
3 | Jacotot E, Talamini L, Bonam SR, Vieira AT, Fremeaux-bacchi V, Radic M, Dragon-durey M, Lozano JM, Saia RS, Muller S. Innate immune responses in COVID-19. Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 2023. [DOI: 10.1016/b978-0-443-18566-3.00041-4] [Reference Citation Analysis] |
4 | Karki R, Kanneganti TD. Innate immunity, cytokine storm, and inflammatory cell death in COVID-19. J Transl Med 2022;20:542. [PMID: 36419185 DOI: 10.1186/s12967-022-03767-z] [Reference Citation Analysis] |
5 | Yi Y. MicroRNA-mediated epigenetic regulation of inflammasomes in inflammatory responses and immunopathologies. Seminars in Cell & Developmental Biology 2022. [DOI: 10.1016/j.semcdb.2022.11.006] [Reference Citation Analysis] |
6 | Sun J, Li Y. Pyroptosis and respiratory diseases: A review of current knowledge. Front Immunol 2022;13:920464. [DOI: 10.3389/fimmu.2022.920464] [Reference Citation Analysis] |
7 | Fu X, Yang Y, Xu W, Li D, Li X, Chen N, Lv Q, Shi Y, Li X, Xu J, Shi F. Coronaviruses using different strategies to antagonize antiviral responses and pyroptosis.. [DOI: 10.1101/2022.07.29.502014] [Reference Citation Analysis] |
8 | Rodrigues TS, Caetano CC, de Sá KS, Almeida L, Becerra A, Gonçalves AV, de Sousa Lopes L, Oliveira S, Mascarenhas DP, Batah SS, Silva BM, Gomes GF, Castro R, Martins RB, Avila J, Frantz FG, Cunha TM, Arruda E, Cunha FQ, Nakaya H, Cunha LD, Fabro AT, Louzada-junior P, de Oliveira RD, Zamboni DS. CASP4/11 contributes to pulmonary inflammation and disease exacerbation in COVID-19.. [DOI: 10.1101/2022.06.29.22277067] [Reference Citation Analysis] |